Annual SGA
$5.67 M
-$1.13 M-16.59%
December 31, 2023
Summary
- As of February 8, 2025, CYTH annual SGA is $5.67 million, with the most recent change of -$1.13 million (-16.59%) on December 31, 2023.
- During the last 3 years, CYTH annual SGA has risen by +$2.49 million (+78.55%).
- CYTH annual SGA is now -16.59% below its all-time high of $6.79 million, reached on December 31, 2022.
Performance
CYTH SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$2.37 M
+$952.40 K+67.31%
September 30, 2024
Summary
- As of February 8, 2025, CYTH quarterly SGA is $2.37 million, with the most recent change of +$952.40 thousand (+67.31%) on September 30, 2024.
- Over the past year, CYTH quarterly SGA has increased by +$968.10 thousand (+69.19%).
- CYTH quarterly SGA is now at all-time high.
Performance
CYTH Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$369.25 M
-$24.80 M-7.20%
September 30, 2024
Summary
- As of February 8, 2025, CYTH TTM SGA is -$369.25 million, with the most recent change of -$24.80 million (-7.20%) on September 30, 2024.
- Over the past year, CYTH TTM SGA has dropped by -$374.92 million (-6617.20%).
- CYTH TTM SGA is now -24465.98% below its all-time high of -$1.50 million.
Performance
CYTH TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
CYTH Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -16.6% | +69.2% | -6617.2% |
| 3 y3 years | +78.5% | +69.2% | -6617.2% |
| 5 y5 years | +172.2% | +69.2% | -6617.2% |
CYTH Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -16.6% | +3.9% | at high | +85.7% | -112.6% | at low |
| 5 y | 5-year | -16.6% | +118.5% | at high | +366.6% | -319.8% | at low |
| alltime | all time | -16.6% | +2255.9% | at high | +7391.5% | <-9999.0% | at low |
Cyclo Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.37 M(+67.3%) | $6.74 M(+14.2%) |
| Jun 2024 | - | $1.41 M(-9.2%) | $5.90 M(+2.4%) |
| Mar 2024 | - | $1.56 M(+11.3%) | $5.76 M(+1.7%) |
| Dec 2023 | $5.67 M(-16.6%) | $1.40 M(-8.5%) | $5.67 M(-5.3%) |
| Sep 2023 | - | $1.53 M(+19.9%) | $5.98 M(-1.2%) |
| Jun 2023 | - | $1.28 M(-12.8%) | $6.06 M(-7.3%) |
| Mar 2023 | - | $1.46 M(-14.9%) | $6.53 M(-3.9%) |
| Dec 2022 | $6.79 M(+24.5%) | $1.72 M(+7.4%) | $6.79 M(+1.7%) |
| Sep 2022 | - | $1.60 M(-8.6%) | $6.68 M(-7.6%) |
| Jun 2022 | - | $1.75 M(+1.4%) | $7.23 M(+13.0%) |
| Mar 2022 | - | $1.73 M(+7.7%) | $6.40 M(+17.3%) |
| Dec 2021 | $5.45 M(+71.9%) | $1.60 M(-25.5%) | $5.45 M(+4.5%) |
| Sep 2021 | - | $2.15 M(+134.6%) | $5.22 M(+46.0%) |
| Jun 2021 | - | $917.10 K(+17.0%) | $3.58 M(+9.7%) |
| Mar 2021 | - | $783.70 K(-42.7%) | $3.26 M(+2.7%) |
| Dec 2020 | $3.17 M(+22.3%) | $1.37 M(+169.6%) | $3.17 M(+30.1%) |
| Sep 2020 | - | $507.40 K(-15.4%) | $2.44 M(-7.7%) |
| Jun 2020 | - | $599.60 K(-14.2%) | $2.64 M(+0.4%) |
| Mar 2020 | - | $698.50 K(+10.3%) | $2.63 M(+1.5%) |
| Dec 2019 | $2.59 M(+24.6%) | $633.30 K(-10.9%) | $2.59 M(+6.1%) |
| Sep 2019 | - | $710.90 K(+20.5%) | $2.44 M(+11.7%) |
| Jun 2019 | - | $590.00 K(-10.5%) | $2.19 M(-1.1%) |
| Mar 2019 | - | $659.50 K(+36.2%) | $2.21 M(+6.3%) |
| Dec 2018 | $2.08 M(-5.9%) | $484.10 K(+6.5%) | $2.08 M(-7.8%) |
| Sep 2018 | - | $454.50 K(-26.0%) | $2.26 M(+2.3%) |
| Jun 2018 | - | $614.00 K(+16.0%) | $2.21 M(-1.6%) |
| Mar 2018 | - | $529.20 K(-19.9%) | $2.24 M(+1.0%) |
| Dec 2017 | $2.21 M(+9.5%) | $660.50 K(+63.4%) | $2.22 M(+10.4%) |
| Sep 2017 | - | $404.30 K(-37.8%) | $2.01 M(-7.1%) |
| Jun 2017 | - | $650.10 K(+28.3%) | $2.17 M(+8.4%) |
| Mar 2017 | - | $506.60 K(+12.5%) | $2.00 M(-1.1%) |
| Dec 2016 | $2.02 M(+6.4%) | $450.50 K(-19.3%) | $2.02 M(-8.0%) |
| Sep 2016 | - | $558.10 K(+15.7%) | $2.20 M(+4.3%) |
| Jun 2016 | - | $482.30 K(-8.9%) | $2.10 M(+2.4%) |
| Mar 2016 | - | $529.30 K(-15.4%) | $2.05 M(+8.2%) |
| Dec 2015 | $1.90 M(+57.8%) | $625.40 K(+34.0%) | $1.90 M(+11.4%) |
| Sep 2015 | - | $466.70 K(+7.8%) | $1.70 M(+6.0%) |
| Jun 2015 | - | $433.10 K(+16.1%) | $1.61 M(+16.6%) |
| Mar 2015 | - | $373.20 K(-13.6%) | $1.38 M(+16.1%) |
| Dec 2014 | $1.20 M(+133.2%) | $431.70 K(+16.8%) | $1.19 M(+37.8%) |
| Sep 2014 | - | $369.60 K(+81.2%) | $862.10 K(+32.5%) |
| Jun 2014 | - | $204.00 K(+11.9%) | $650.60 K(+13.8%) |
| Mar 2014 | - | $182.30 K(+71.7%) | $571.90 K(+10.8%) |
| Dec 2013 | $516.00 K(+8.5%) | $106.20 K(-32.8%) | $516.00 K(+3.5%) |
| Sep 2013 | - | $158.10 K(+26.2%) | $498.70 K(+12.0%) |
| Jun 2013 | - | $125.30 K(-0.9%) | $445.40 K(+4.7%) |
| Mar 2013 | - | $126.40 K(+42.2%) | $425.40 K(-10.5%) |
| Dec 2012 | $475.40 K | $88.90 K(-15.2%) | $475.40 K(+3.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | $104.80 K(-0.5%) | $458.00 K(-22.1%) |
| Jun 2012 | - | $105.30 K(-40.3%) | $587.70 K(-6.0%) |
| Mar 2012 | - | $176.40 K(+146.7%) | $625.30 K(-4.4%) |
| Dec 2011 | $654.20 K(-3.6%) | $71.50 K(-69.5%) | $654.20 K(-11.8%) |
| Sep 2011 | - | $234.50 K(+64.1%) | $742.00 K(+9.1%) |
| Jun 2011 | - | $142.90 K(-30.4%) | $680.00 K(+5.4%) |
| Mar 2011 | - | $205.30 K(+28.9%) | $644.90 K(-5.0%) |
| Dec 2010 | $678.60 K(-2.1%) | $159.30 K(-7.7%) | $678.60 K(-15.5%) |
| Sep 2010 | - | $172.50 K(+60.0%) | $803.20 K(+4.1%) |
| Jun 2010 | - | $107.80 K(-54.9%) | $771.70 K(-0.9%) |
| Mar 2010 | - | $239.00 K(-15.8%) | $778.60 K(+12.3%) |
| Dec 2009 | $693.30 K(+33.3%) | $283.90 K(+101.3%) | $693.30 K(+27.4%) |
| Sep 2009 | - | $141.00 K(+22.9%) | $544.20 K(-0.2%) |
| Jun 2009 | - | $114.70 K(-25.4%) | $545.10 K(-0.2%) |
| Mar 2009 | - | $153.70 K(+14.0%) | $546.40 K(+3.6%) |
| Dec 2008 | $520.10 K(+18.4%) | $134.80 K(-5.0%) | $527.20 K(+10.1%) |
| Sep 2008 | - | $141.90 K(+22.3%) | $478.70 K(+5.5%) |
| Jun 2008 | - | $116.00 K(-13.8%) | $453.80 K(+7.4%) |
| Mar 2008 | - | $134.50 K(+55.9%) | $422.70 K(-3.7%) |
| Dec 2007 | $439.10 K(+25.2%) | $86.30 K(-26.2%) | $439.10 K(+14.2%) |
| Sep 2007 | - | $117.00 K(+37.8%) | $384.40 K(-0.2%) |
| Jun 2007 | - | $84.90 K(-43.7%) | $385.20 K(-4.4%) |
| Mar 2007 | - | $150.90 K(+377.5%) | $402.90 K(+14.9%) |
| Dec 2006 | $350.70 K(-29.9%) | $31.60 K(-73.2%) | $350.70 K(-18.8%) |
| Sep 2006 | - | $117.80 K(+14.8%) | $432.00 K(-12.1%) |
| Jun 2006 | - | $102.60 K(+4.0%) | $491.60 K(-0.4%) |
| Mar 2006 | - | $98.70 K(-12.6%) | $493.60 K(-1.3%) |
| Dec 2005 | $500.30 K(-24.7%) | $112.90 K(-36.4%) | $500.30 K(-29.4%) |
| Sep 2005 | - | $177.40 K(+69.6%) | $708.70 K(+10.1%) |
| Jun 2005 | - | $104.60 K(-0.8%) | $643.60 K(+1.4%) |
| Mar 2005 | - | $105.40 K(-67.2%) | $634.50 K(-4.6%) |
| Dec 2004 | $664.80 K(+131.9%) | $321.30 K(+186.1%) | $664.80 K(+36.0%) |
| Sep 2004 | - | $112.30 K(+17.6%) | $488.70 K(+15.8%) |
| Jun 2004 | - | $95.50 K(-29.6%) | $421.90 K(+13.0%) |
| Mar 2004 | - | $135.70 K(-6.5%) | $373.20 K(+30.2%) |
| Dec 2003 | $286.70 K(+19.2%) | $145.20 K(+219.1%) | $286.70 K(+34.2%) |
| Sep 2003 | - | $45.50 K(-2.8%) | $213.70 K(-1.2%) |
| Jun 2003 | - | $46.80 K(-4.9%) | $216.40 K(-4.4%) |
| Mar 2003 | - | $49.20 K(-31.9%) | $226.40 K(-5.9%) |
| Dec 2002 | $240.50 K(-13.8%) | $72.20 K(+49.8%) | $240.60 K(+2.9%) |
| Sep 2002 | - | $48.20 K(-15.1%) | $233.90 K(-10.2%) |
| Jun 2002 | - | $56.80 K(-10.4%) | $260.60 K(-2.7%) |
| Mar 2002 | - | $63.40 K(-3.2%) | $267.80 K(-4.0%) |
| Dec 2001 | $279.10 K(-26.8%) | $65.50 K(-12.6%) | $279.10 K(-21.5%) |
| Sep 2001 | - | $74.90 K(+17.0%) | $355.40 K(-0.4%) |
| Jun 2001 | - | $64.00 K(-14.3%) | $356.80 K(+21.9%) |
| Mar 2001 | - | $74.70 K(-47.3%) | $292.80 K(+34.3%) |
| Dec 2000 | $381.40 K | $141.80 K(+85.8%) | $218.10 K(+185.8%) |
| Sep 2000 | - | $76.30 K | $76.30 K |
FAQ
- What is Cyclo Therapeutics annual SGA?
- What is the all time high annual SGA for Cyclo Therapeutics?
- What is Cyclo Therapeutics annual SGA year-on-year change?
- What is Cyclo Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Cyclo Therapeutics?
- What is Cyclo Therapeutics quarterly SGA year-on-year change?
- What is Cyclo Therapeutics TTM SGA?
- What is the all time high TTM SGA for Cyclo Therapeutics?
- What is Cyclo Therapeutics TTM SGA year-on-year change?
What is Cyclo Therapeutics annual SGA?
The current annual SGA of CYTH is $5.67 M
What is the all time high annual SGA for Cyclo Therapeutics?
Cyclo Therapeutics all-time high annual SGA is $6.79 M
What is Cyclo Therapeutics annual SGA year-on-year change?
Over the past year, CYTH annual SGA has changed by -$1.13 M (-16.59%)
What is Cyclo Therapeutics quarterly SGA?
The current quarterly SGA of CYTH is $2.37 M
What is the all time high quarterly SGA for Cyclo Therapeutics?
Cyclo Therapeutics all-time high quarterly SGA is $2.37 M
What is Cyclo Therapeutics quarterly SGA year-on-year change?
Over the past year, CYTH quarterly SGA has changed by +$968.10 K (+69.19%)
What is Cyclo Therapeutics TTM SGA?
The current TTM SGA of CYTH is -$369.25 M
What is the all time high TTM SGA for Cyclo Therapeutics?
Cyclo Therapeutics all-time high TTM SGA is -$1.50 M
What is Cyclo Therapeutics TTM SGA year-on-year change?
Over the past year, CYTH TTM SGA has changed by -$374.92 M (-6617.20%)